Charlotte's Web Holdings stock analysis
Want to see TSE:CWEB full AI Analyst Report?
Charlotte's Web Holdings (CWEB) Stock Price & Analysis
CWEB Stock Chart & Stats
- Day’s Range
- CAD 0.25 - CAD 0.26
- 52-Week Range
- CAD 0.12 - CAD 1.33
- Previous Close
- CAD 0.26
- Volume
- N/A
- Average Volume (3M)
- 39.86K
- Market Cap
- CAD 66.47M
- Enterprise Value
- CAD 106.31M
- Total Cash (Recent Filing)
- CAD 11.29M
- Total Debt (Recent Filing)
- CAD 12.61M
- Price to Earnings (P/E)
- ―
- Beta
- 1.13
- Next Earnings
- Mar 25, 2027 (Est.)
- EPS Estimate
- -0.03
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Diversified CBD Product Portfolio
A broad branded portfolio across human wellness, ingestibles, topical products, and pet care gives Charlotte's Web several avenues to reach consumers. This category diversification can support cross-selling and reduce reliance on a single product format as preferences evolve over the next several quarters.
Improved Balance Sheet
Very low leverage and restored positive equity represent a meaningful improvement in financial stability versus earlier periods. Lower debt obligations provide greater flexibility to manage ongoing losses, preserve operating capacity, and allocate resources toward the business without the same balance-sheet pressure.
Stable Gross Margin
Relatively stable gross margins indicate that the company continues to retain a consistent portion of sales after product costs despite weak overall profitability. This provides a more durable base for improvement if revenue stabilizes and operating expenses are brought into better alignment with the business.
Bears Say
Declining Revenue
Persistent revenue contraction signals that the company has not yet established durable top-line momentum in its CBD wellness markets. Continued declines can reduce operating leverage, weaken brand investment capacity, and make it harder to absorb fixed costs over the next several quarters.
Severe Unprofitability
Large operating and net losses show that the current revenue base is not supporting a sustainable cost structure. Although losses have narrowed from earlier extremes, the depth of the remaining deficits constrains reinvestment, erodes financial resilience, and leaves profitability dependent on substantial execution improvement.
Ongoing Cash Burn
Negative operating and free cash flow means the business is still consuming cash rather than funding operations internally. Continued burn can require financing or use of balance-sheet resources, reducing flexibility and increasing the importance of a sustained improvement in sales and operating performance.
Charlotte's Web Holdings News
CWEB FAQ
What was Charlotte's Web Holdings’s price range in the past 12 months?
What is Charlotte's Web Holdings’s market cap?
When is Charlotte's Web Holdings’s upcoming earnings report date?
How were Charlotte's Web Holdings’s earnings last quarter?
Is Charlotte's Web Holdings overvalued?
Does Charlotte's Web Holdings pay dividends?
What is Charlotte's Web Holdings’s EPS estimate?
How many shares outstanding does Charlotte's Web Holdings have?
What happened to Charlotte's Web Holdings’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Charlotte's Web Holdings?
What is the TipRanks Smart Score and how is it calculated?
Charlotte's Web Holdings Stock Smart Score
Company Description
Charlotte's Web Holdings
Charlotte's Web Holdings, Inc. specializes in the cultivation, manufacturing, marketing, and distribution of hemp-derived cannabidiol (CBD) wellness products. Their extensive product range includes liquid hemp extract tinctures, various gummies (designed for sleep, stress relief, immune support, and exercise recovery), capsules, topical CBD creams and lotions, and specific offerings for pets. These are sold under prominent brands such as Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp. Each product is formulated with naturally occurring phytocannabinoids like CBD, cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), along with terpenes, flavonoids, and a spectrum of other beneficial hemp compounds. The company reaches its customers through multiple channels, including traditional retail outlets, health care practitioners, and direct-to-consumer sales via its official website. Charlotte's Web actively advances hemp cannabinoid science through key collaborations. Its CW Labs division works with the University at Buffalo's Center for Integrated Global Biomedical Sciences on a dedicated research program, and it also maintains a scientific partnership with McLean Hospital. Founded in 2013 and headquartered in Denver, Colorado, the company was formerly known as Stanley Brothers Holdings Inc. before officially changing its name to Charlotte's Web Holdings, Inc. in July 2018.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- William Morachnick
- Employees
- 112
- Website
- www.charlottesweb.com
- Address
- 700 Tech Court, Louisville, CO, 80027, US
Charlotte's Web Holdings (CWEB) Earnings & Revenues
CWEB Earnings Call
Earnings Call SentimentPositive
The call emphasized several transformative, strategic positives — a balance-sheet‑clearing BAT transaction with fresh capital, federal Medicare pilot eligibility (Substance Access BEI) allowing full‑spectrum CBD access into accountable care channels, meaningful clinical progress via DeFloria's Phase II clearance, substantial cost reductions (SG&A down ~21% YoY and ~44.5% over two years), and improved operating loss and margin runways. These positives are tempered by ongoing regulatory uncertainty (including a potential November 2026 hemp provision that could severely constrain the market), persistent net losses (Q4 net loss $11.4M; full‑year net loss ~$29.7M), a nonrecurring $1.3M inventory charge that depressed reported margins, and liquidity dependence on shareholder approval of the BAT transaction. On balance, the call conveyed constructive momentum and multiple high‑impact catalysts that materially improve the company’s strategic position, while acknowledging meaningful near‑term risks and the gradual timing of revenue realization from Medicare pilots.
View all TSE:CWEB earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 2 | 6 | 14 |
| Technical Analysis | 2 | 6 | 2 |
| Moving Averages | 0 | 0 | 12 |











